Bioatla Inc
BCAB0.342USD
+0.012+3.58%
交易中 （美東）報價延遲15分鐘
19.96M總市值
虧損本益比TTM
關於 Bioatla Inc 公司
BioAtla, Inc. 是一家臨牀階段生物製藥公司，專注於開發用於治療實體瘤癌症的抗體療法。該公司的候選產品包括 Mecbotamab vedotin (BA3011)、Ozuriftabmab vedotin (BA3021)、BA3071 和 BA3182。其主要候選產品 BA3011 是一種有條件活性的生物製劑 (CAB) 抗體-藥物偶聯物 (ADC)，靶向蛋白激酶受體 AXL。BA3071 是多種實體瘤類型的潛在治療劑，包括軟組織和骨肉瘤以及非小細胞肺癌 (NSCLC)。BA3021 正在開發一種針對受體酪氨酸激酶（如孤兒受體 2 (ROR2)）的 CAB 抗體藥物偶聯物。BA3071 是一種 CAB 抗 CTLA-4 抗體，正在開發用於治療多種實體瘤適應症。 BA3182 設計有 EpCAM 結合域和 CD3 結合域，兩個結合域均具有 CAB 活性（Dual-CAB），用於治療晚期腺癌。
公司簡介
公司代碼BCAB
公司名稱Bioatla Inc
上市日期Dec 16, 2020
CEODr. Jay M. Short, Ph.D.
員工數量61
證券類型Ordinary Share
年結日Dec 16
公司地址11085 Torreyana Road
城市SAN DIEGO
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編92121
電話18585580708
網址https://www.bioatla.com/
公司代碼BCAB
上市日期Dec 16, 2020
CEODr. Jay M. Short, Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Jay M. Short, Ph.D.
Dr. Jay M. Short, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.53M
-0.25%
Dr. Eric L. Sievers, M.D.
Dr. Eric L. Sievers, M.D.
Chief Medical Officer
Chief Medical Officer
409.85K
-0.66%
Mr. Richard A. Waldron
Mr. Richard A. Waldron
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
391.29K
-0.60%
Dr. Lawrence Steinman, M.D.
Dr. Lawrence Steinman, M.D.
Lead Independent Director
Lead Independent Director
144.27K
+19.46%
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
143.20K
+19.63%
Dr. Susan Moran, M.D.
Dr. Susan Moran, M.D.
Independent Director
Independent Director
118.11K
+24.84%
Mr. Edward L. (Eddie) Williams
Mr. Edward L. (Eddie) Williams
Independent Director
Independent Director
--
--
Mr. Scott A. Smith
Mr. Scott A. Smith
Director
Director
--
--
Ms. Sylvia Mcbrinn
Ms. Sylvia Mcbrinn
Independent Director
Independent Director
--
--
Mr. Christian Vasquez, CPA
Mr. Christian Vasquez, CPA
Chief Accounting Officer, Controller, Corporate Secretary
Chief Accounting Officer, Controller, Corporate Secretary
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Jay M. Short, Ph.D.
Dr. Jay M. Short, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.53M
-0.25%
Dr. Eric L. Sievers, M.D.
Dr. Eric L. Sievers, M.D.
Chief Medical Officer
Chief Medical Officer
409.85K
-0.66%
Mr. Richard A. Waldron
Mr. Richard A. Waldron
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
391.29K
-0.60%
Dr. Lawrence Steinman, M.D.
Dr. Lawrence Steinman, M.D.
Lead Independent Director
Lead Independent Director
144.27K
+19.46%
Dr. Mary Ann Gray, Ph.D.
Dr. Mary Ann Gray, Ph.D.
Independent Director
Independent Director
143.20K
+19.63%
Dr. Susan Moran, M.D.
Dr. Susan Moran, M.D.
Independent Director
Independent Director
118.11K
+24.84%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月22日 週四
更新時間: 5月22日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Acorn Capital Advisors, LLC
8.28%
OPOKA Towarzystwo Funduszy Inwestycyjnych S.A.
6.07%
Short (Jay M)
4.33%
The Vanguard Group, Inc.
3.11%
Acadian Asset Management LLC
2.89%
Other
75.32%
持股股東
持股股東
佔比
Acorn Capital Advisors, LLC
8.28%
OPOKA Towarzystwo Funduszy Inwestycyjnych S.A.
6.07%
Short (Jay M)
4.33%
The Vanguard Group, Inc.
3.11%
Acadian Asset Management LLC
2.89%
Other
75.32%
股東類型
持股股東
佔比
Investment Advisor
21.24%
Individual Investor
11.12%
Investment Advisor/Hedge Fund
4.75%
Hedge Fund
4.60%
Research Firm
1.20%
Sovereign Wealth Fund
0.67%
Pension Fund
0.04%
Private Equity
0.02%
Other
56.36%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
222
25.48M
43.62%
-17.81M
2025Q1
236
24.74M
42.74%
-20.20M
2024Q4
263
32.45M
57.22%
-12.96M
2024Q3
259
29.88M
61.37%
-17.19M
2024Q2
266
34.25M
70.95%
-15.78M
2024Q1
275
36.99M
76.93%
-12.58M
2023Q4
283
37.85M
79.00%
-13.74M
2023Q3
290
39.74M
85.24%
-20.01M
2023Q2
294
41.64M
89.42%
-15.48M
2023Q1
295
41.22M
88.67%
-9.50M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Acorn Capital Advisors, LLC
4.84M
8.28%
+803.07K
+19.92%
May 15, 2025
OPOKA Towarzystwo Funduszy Inwestycyjnych S.A.
3.55M
6.07%
+3.55M
--
Mar 06, 2025
Short (Jay M)
2.53M
4.33%
-6.35K
-0.25%
May 31, 2025
The Vanguard Group, Inc.
1.82M
3.11%
-14.47K
-0.79%
Mar 31, 2025
Acadian Asset Management LLC
1.69M
2.89%
+1.53M
+968.91%
Mar 31, 2025
Tang Capital Management, LLC
1.37M
2.35%
--
--
Mar 31, 2025
Short (Carolyn Anderson)
1.35M
2.32%
--
--
Apr 21, 2025
Smith Scott Andrew
852.35K
1.46%
+23.50K
+2.84%
Jun 18, 2025
Aguja Capital GmbH
750.00K
1.28%
--
--
Feb 28, 2025
Renaissance Technologies LLC
744.83K
1.27%
-84.76K
-10.22%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
DFA Dimensional US Sustainability Core 1 ETF
0%
ProShares UltraPro Russell2000
0%
Global X Russell 2000 Covered Call ETF
0%
Global X Russell 2000 ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
ProShares Hedge Replication ETF
0%
Avantis US Small Cap Equity ETF
0%
Proshares Ultra Russell 2000
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
查看更多
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Global X Russell 2000 Covered Call ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
ProShares Ultra Nasdaq Biotechnology
佔比0%
ProShares Hedge Replication ETF
佔比0%
Avantis US Small Cap Equity ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
